US Stock MarketDetailed Quotes
MRNS Marinus Pharmaceuticals
- 0.230
- -0.009-3.56%
Close Dec 20 16:00 ET
- 0.233
- +0.003+1.39%
Post 20:01 ET
12.69MMarket Cap-0.09P/E (TTM)
0.247High0.230Low1.14MVolume0.241Open0.239Pre Close270.25KTurnover2.84%Turnover RatioLossP/E (Static)55.19MShares11.26052wk High-0.19P/B9.20MFloat Cap0.23052wk Low--Dividend TTM39.98MShs Float82.880Historical High--Div YieldTTM7.21%Amplitude0.230Historical Low0.237Avg Price1Lot Size
Marinus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.39%8.54M | 32.48%8.06M | -26.02%7.68M | 21.63%30.99M | 0.39%7.19M | 213.59%7.34M | 239.72%6.08M | -26.83%10.38M | 66.03%25.48M | 371.18%7.16M |
| Operating revenue | 16.39%8.54M | 32.48%8.06M | -26.02%7.68M | 21.63%30.99M | 0.39%7.19M | 213.59%7.34M | 239.72%6.08M | -26.83%10.38M | 66.03%25.48M | 371.18%7.16M |
| Cost of revenue | 56.92%714K | 90.41%735K | 266.99%756K | 468.82%1.93M | 203.77%887K | 847.92%455K | 386K | 206K | -77.00%340K | 292K |
| Gross profit | 13.71%7.83M | 28.55%7.32M | -31.95%6.92M | 15.58%29.06M | -8.25%6.3M | 200.31%6.88M | 218.16%5.7M | -28.28%10.17M | 81.28%25.14M | 351.97%6.87M |
| Operating expense | -24.97%28.91M | 1.27%37.61M | -0.91%42.74M | 16.40%160.54M | 15.68%41.74M | 18.95%38.53M | -3.69%37.13M | 39.62%43.14M | 24.48%137.93M | 26.00%36.08M |
| Selling and administrative expenses | -15.44%12.57M | 6.28%16.71M | 22.51%18.63M | 7.58%61.15M | 4.78%15.36M | 11.05%14.87M | -7.85%15.72M | 29.54%15.2M | 52.49%56.85M | 38.00%14.66M |
| Research and development costs | -30.97%16.33M | -2.41%20.9M | -13.66%24.12M | 24.37%99.39M | 23.14%26.38M | 24.52%23.66M | -0.39%21.41M | 55.26%27.93M | 8.69%79.91M | 18.93%21.42M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.17M | --0 |
| Operating profit | 33.39%-21.08M | 3.67%-30.29M | -8.67%-35.82M | -16.58%-131.49M | -21.31%-35.44M | -5.14%-31.65M | 14.49%-31.44M | -97.25%-32.96M | -16.36%-112.79M | -7.73%-29.21M |
| Net non-operating interest income expense | -38.26%-3.25M | -68.65%-3.51M | -59.87%-2.88M | -5.58%-8.78M | -31.09%-2.55M | -10.71%-2.35M | 19.13%-2.08M | -7.38%-1.8M | -232.45%-8.32M | -27.19%-1.95M |
| Non-operating interest income | -68.44%598K | -47.89%1.11M | -37.60%1.46M | 244.65%8.11M | 0.17%1.75M | 268.68%1.9M | 2,433.33%2.13M | 19,425.00%2.34M | 2,842.50%2.35M | 7,482.61%1.74M |
| Non-operating interest expense | -9.41%3.84M | 9.72%4.62M | 4.80%4.35M | 58.31%16.9M | 16.48%4.3M | 61.05%4.24M | 58.43%4.21M | 145.09%4.15M | 313.32%10.67M | 137.60%3.69M |
| Other net income (expense) | -90.21%100K | -4,427.66%-2.03M | -2.70%36K | -102.56%-2.68M | -149.24%-3.78M | -99.05%1.02M | 149.47%47K | 103.81%37K | 15,832.88%104.68M | -544.87%-1.52M |
| Special income (charges) | --0 | ---1.95M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --0 | --1.95M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -90.21%100K | -278.72%-84K | -2.70%36K | -102.56%-2.68M | -149.24%-3.78M | -99.05%1.02M | 149.47%47K | 103.81%37K | 15,832.88%104.68M | -544.87%-1.52M |
| Income before tax | 26.53%-24.23M | -7.04%-35.83M | -11.34%-38.67M | -770.17%-142.94M | -27.83%-41.77M | -143.94%-32.97M | 15.12%-33.47M | -79.38%-34.73M | 83.37%-16.43M | -15.44%-32.68M |
| Income tax | 0 | 0 | -145.38%-1.54M | 0 | 0 | -1.54M | 3.39M | 1.64M | ||
| Net income | 26.53%-24.23M | -12.19%-35.83M | -11.34%-38.67M | -613.59%-141.41M | -21.73%-41.77M | -144.99%-32.97M | 19.02%-31.93M | -79.38%-34.73M | 79.94%-19.82M | -21.22%-34.31M |
| Net income continuous Operations | 26.53%-24.23M | -12.19%-35.83M | -11.34%-38.67M | -613.59%-141.41M | -21.73%-41.77M | -144.99%-32.97M | 19.02%-31.93M | -79.38%-34.73M | 79.94%-19.82M | -21.22%-34.31M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 26.53%-24.23M | -12.19%-35.83M | -11.34%-38.67M | -613.59%-141.41M | -21.73%-41.77M | -144.99%-32.97M | 19.02%-31.93M | -79.38%-34.73M | 79.94%-19.82M | -21.22%-34.31M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 26.53%-24.23M | -12.19%-35.83M | -11.34%-38.67M | -613.59%-141.41M | -22.94%-41.77M | -146.03%-32.97M | 19.02%-31.93M | -79.38%-34.73M | 79.94%-19.82M | -20.04%-33.98M |
| Basic earnings per share | 31.15%-0.42 | -3.28%-0.63 | -1.49%-0.68 | -415.69%-2.63 | 2.63%-0.74 | -131.61%-0.61 | 42.45%-0.61 | -28.85%-0.67 | 81.04%-0.51 | 1.30%-0.76 |
| Diluted earnings per share | 31.15%-0.42 | -3.28%-0.63 | -1.49%-0.68 | -415.69%-2.63 | 2.63%-0.74 | -132.28%-0.61 | 42.45%-0.61 | -28.85%-0.67 | 81.04%-0.51 | 1.30%-0.76 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data